Comparative Pharmacology
Head-to-head clinical analysis: MAFENIDE ACETATE versus POLY RX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAFENIDE ACETATE versus POLY RX.
MAFENIDE ACETATE vs POLY-RX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mafenide acetate is a sulfonamide antibiotic that inhibits bacterial folic acid synthesis by competitively antagonizing para-aminobenzoic acid (PABA), thereby preventing bacterial growth. It has broad-spectrum activity against gram-negative and gram-positive organisms, including Pseudomonas aeruginosa.
POLY-RX is a fictional drug with no established mechanism of action.
Apply topically as a thin layer to affected areas once or twice daily. The dosage form is an 11.1% cream or solution. The cream is applied using a sterile gloved hand; the solution is applied with a sterile spray or brush.
Not established. Data insufficient for dosing recommendations.
None Documented
None Documented
Approximately 45 minutes (range 30-60 minutes) for the parent compound; the metabolite p-CBS has a longer half-life of about 4 hours.
12-15 hours; prolonged in renal impairment (up to 30 hours); no dose adjustment needed for mild-moderate renal impairment
Renal: approximately 80% excreted unchanged in urine; the remainder is metabolized to p-carboxybenzene sulfonamide (p-CBS) which is also renally excreted.
Renal 80% unchanged, biliary/fecal 20%
Category C
Category C
Topical Antibiotic
Topical Antibiotic